BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3520683)

  • 1. [Mechanism of induction of parkinsonism by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin].
    Hirata Y; Nagatsu T
    Tanpakushitsu Kakusan Koso; 1986 Apr; 31(5):398-409. PubMed ID: 3520683
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxins and Parkinson's disease: MPTP parkinsonism in humans and animals.
    Kopin IJ
    Adv Neurol; 1987; 45():137-44. PubMed ID: 3493621
    [No Abstract]   [Full Text] [Related]  

  • 3. MPTP: a pharmacological tool to study parkinsonism.
    Kulkarni SK; Mehta AK; Aley KO; Shukla VK
    Methods Find Exp Clin Pharmacol; 1986 Aug; 8(8):485-9. PubMed ID: 3489146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): one designer drug and serendipity.
    Weingarten HL
    J Forensic Sci; 1988 Mar; 33(2):588-95. PubMed ID: 3259617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical syndrome of striatal dopamine deficiency: parkinsonism induced by MPTP.
    Eldridge R; Rocca WA
    N Engl J Med; 1985 Oct; 313(18):1159-60. PubMed ID: 3876508
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig, and monkey.
    Chiueh CC; Markey SP; Burns RS; Johannessen JN; Jacobowitz DM; Kopin IJ
    Psychopharmacol Bull; 1984; 20(3):548-53. PubMed ID: 6332333
    [No Abstract]   [Full Text] [Related]  

  • 7. Saccade responses to dopamine in human MPTP-induced parkinsonism.
    Hotson JR; Langston EB; Langston JW
    Ann Neurol; 1986 Oct; 20(4):456-63. PubMed ID: 3491578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MPTP-induced parkinsonism. Recent studies on the mechanism of toxicity.
    Bocchetta A; Piccardi MP; Zuddas A; Bernardi F; Zompo MD; Corsini GU
    Funct Neurol; 1988; 3(4):439-47. PubMed ID: 3072279
    [No Abstract]   [Full Text] [Related]  

  • 9. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man.
    Burns RS; Markey SP; Phillips JM; Chiueh CC
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):166-8. PubMed ID: 6608980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on MPTP-induced parkinsonian animal model in rhesus monkey and the mechanism of MPTP.
    Chen SD; Xu DL; Yu HZ; Tang QM; Xu XR; Wang ZG; Liang PF
    Chin Med J (Engl); 1988 Dec; 101(12):879-83. PubMed ID: 3150735
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathology of MPTP in the marmoset.
    Gibb WR; Lees AJ; Wells FR; Barnard RO; Jenner P; Marsden CD
    Adv Neurol; 1987; 45():187-90. PubMed ID: 3103386
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of increasing regimens of levodopa on chronic MPTP-induced parkinsonism in monkey; mechanographic and electromyographic data.
    Doudet D; Gross C; Lebrun-Grandie P; Bioulac B
    Electromyogr Clin Neurophysiol; 1986 Dec; 26(8):711-27. PubMed ID: 3493894
    [No Abstract]   [Full Text] [Related]  

  • 13. Parkinson-like syndrome in nonhuman primates receiving a tetrahydropyridine derivative.
    Barsoum NJ; Gough AW; Sturgess JM; de la Iglesia FA
    Neurotoxicology; 1986; 7(1):119-26. PubMed ID: 3487056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MPTP and parkinsonism.
    Bianchine JR; McGhee B
    Ration Drug Ther; 1985 Feb; 19(2):5-7. PubMed ID: 3876575
    [No Abstract]   [Full Text] [Related]  

  • 15. [The bases of MPTP neurotoxicity].
    Dostert P; Strolin Benedetti M
    Encephale; 1988; 14(6):399-412. PubMed ID: 3068045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the monkey: neurochemical pathology and regional brain metabolism.
    Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
    J Neural Transm Suppl; 1986; 20():41-6. PubMed ID: 3462325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New clues to the etiology of Parkinson disease: parkinsonism induced by the neurotoxin MPTP].
    Jonsson G; Sundström E
    Lakartidningen; 1986 Jan; 83(4):215-8. PubMed ID: 3485230
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoradiographic distributions of neurotransmitter receptors in the human brains of Parkinson's disease and primate models of MPTP-induced parkinsonism.
    Kito S; Miyoshi R; Mizuno K; Nitta K; Matsubayashi H; Yamamura Y; Tahara E
    Adv Neurol; 1987; 45():159-65. PubMed ID: 2881441
    [No Abstract]   [Full Text] [Related]  

  • 19. Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP.
    Javitch JA; Snyder SH
    Eur J Pharmacol; 1984 Nov; 106(2):455-6. PubMed ID: 6335692
    [No Abstract]   [Full Text] [Related]  

  • 20. The action of MPTP on Macaca fascicularis nigral neurons.
    Levi AC; De Mattei M; Ravazzani R; Fariello GR; Corvetti G
    Boll Soc Ital Biol Sper; 1987 Apr; 63(4):365-8. PubMed ID: 3502324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.